Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- PE ratio
- —
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 41,500
- Avg volume
- 46,744
- Day's range
- $0.10 – $0.10
- Shares out
- —
- Stochastic %K
- 96%
- Beta
- —
- Analysts
- Strong Buy
- Price target
- —
Company profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. The company has a collabora...
Show more
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in acquiring, exploring, and developing raw materials for pharmaceutical products in the United States of America, the province of British Columbia, Canada, and the state of Utah. It develops barium and iodine-based APIs. The company offers Smooth HD, Smooth X, Smooth LD, Vision HD, Vision LD, V-Gas, and other products. The company has a collaboration with Bayer for the research and development of evaluating potential future production of iodine to be used in contrast media drugs. Voyageur Pharmaceuticals Ltd. was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. The company is headquartered in Calgary, Canada.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 877 398 6866
- Website
- https://voyageurpharmaceuticals.ca
- Address
- 4103 Centre Street NW, Calgary, Canada
Latest news
No headlines yet.
